Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Febbraio

Showing results (211-220 of 219) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 219 results.
Cell|March 29, 2024
Embracing cancer complexity: Hallmarks of systemic diseaseCharles Swanton, Elsa Bernard, Chris Abbosh, et al.
Circulation|March 26, 2014
Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in miceDennis Wolf, Felix Jehle, Nathaly Anto Michel, et al.
Annals of the New York Academy of Sciences|March 24, 2023
Immunometabolism at the crossroads of obesity and cancer-a Keystone Symposia reportJennifer Cable, Jeffrey C Rathmell, Erika L Pearce, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2025
PSKH1 kinase activity is differentially modulated via allosteric binding of Ca<sup>2+</sup> sensor proteinsChristopher R Horne, Toby A Dite, Samuel N Young, et al.
Journal of Sport and Health Science|September 28, 2024
Decorin, an exercise-induced secretory protein, is associated with improved prognosis in breast cancer patients but does not mediate anti-tumorigenic tissue crosstalk in miceMarit Hjorth, Casey L Egan, Guilherme D Telles, et al.
Science Advances|October 24, 2025
The designer cytokine IC7Fc attenuates atherosclerosis development by targeting hyperlipidemia in miceWietse In Het Panhuis, Ellen Thiemann, Daisy M A H van Dijk, et al.
Current Pharmaceutical Design|August 28, 2012
Hydroximic acid derivatives: pleiotropic HSP co-inducers restoring homeostasis and robustnessTim Crul, Noemi Toth, Stefano Piotto, et al.
Nature|September 27, 2019
Treatment of type 2 diabetes with the designer cytokine IC7FcMaria Findeisen, Tamara L Allen, Darren C Henstridge, et al.
Intensive Care Medicine|November 3, 2025
The intensive care medicine research agenda for the management of ICU acquired weakness: a multinational, interprofessional perspectiveSabrina Eggmann, Selina M Parry, Tessa Broadley, et al.
Pageof 22

Showing results (211-220 of 219) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 219 results.
Cell|March 29, 2024
Embracing cancer complexity: Hallmarks of systemic diseaseCharles Swanton, Elsa Bernard, Chris Abbosh, et al.
Circulation|March 26, 2014
Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in miceDennis Wolf, Felix Jehle, Nathaly Anto Michel, et al.
Annals of the New York Academy of Sciences|March 24, 2023
Immunometabolism at the crossroads of obesity and cancer-a Keystone Symposia reportJennifer Cable, Jeffrey C Rathmell, Erika L Pearce, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2025
PSKH1 kinase activity is differentially modulated via allosteric binding of Ca<sup>2+</sup> sensor proteinsChristopher R Horne, Toby A Dite, Samuel N Young, et al.
Journal of Sport and Health Science|September 28, 2024
Decorin, an exercise-induced secretory protein, is associated with improved prognosis in breast cancer patients but does not mediate anti-tumorigenic tissue crosstalk in miceMarit Hjorth, Casey L Egan, Guilherme D Telles, et al.
Science Advances|October 24, 2025
The designer cytokine IC7Fc attenuates atherosclerosis development by targeting hyperlipidemia in miceWietse In Het Panhuis, Ellen Thiemann, Daisy M A H van Dijk, et al.
Current Pharmaceutical Design|August 28, 2012
Hydroximic acid derivatives: pleiotropic HSP co-inducers restoring homeostasis and robustnessTim Crul, Noemi Toth, Stefano Piotto, et al.
Nature|September 27, 2019
Treatment of type 2 diabetes with the designer cytokine IC7FcMaria Findeisen, Tamara L Allen, Darren C Henstridge, et al.
Intensive Care Medicine|November 3, 2025
The intensive care medicine research agenda for the management of ICU acquired weakness: a multinational, interprofessional perspectiveSabrina Eggmann, Selina M Parry, Tessa Broadley, et al.
Pageof 22